These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 10504548)

  • 1. Expression of Bcl-2, but not Bax, correlates with estrogen receptor status and tumor proliferation in invasive breast carcinoma.
    Yang Q; Sakurai T; Jing X; Utsunomiya H; Shan L; Nakamura Y; Nakamura M; Oura S; Suzuma T; Yoshimura G; Umemura T; Kokawa Y; Kakudo K
    Pathol Int; 1999 Sep; 49(9):775-80. PubMed ID: 10504548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer.
    Linjawi A; Kontogiannea M; Halwani F; Edwardes M; Meterissian S
    J Am Coll Surg; 2004 Jan; 198(1):83-90. PubMed ID: 14698315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical status of p53, MDM2, bcl2, bax, and ER in invasive ductal breast carcinoma in Tunisian patients.
    Baccouche S; Daoud J; Frikha M; Mokdad-Gargouri R; Gargouri A; Jlidi R
    Ann N Y Acad Sci; 2003 Dec; 1010():752-63. PubMed ID: 15033823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunofluorometric study of Bcl-2 and Bax expression in clinical fresh tumor samples from breast cancer patients.
    Martínez-Arribas F; Núñez-Villar MJ; Lucas AR; Sánchez J; Tejerina A; Schneider J
    Anticancer Res; 2003; 23(1B):565-8. PubMed ID: 12680147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bax protein expression in DCIS of the breast in relation to invasive ductal carcinoma and other molecular markers.
    Rehman S; Crow J; Revell PA
    Pathol Oncol Res; 2000; 6(4):256-63. PubMed ID: 11173657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl-2 protein expression is associated with p27 and p53 protein expressions and MIB-1 counts in breast cancer.
    Tsutsui S; Yasuda K; Suzuki K; Takeuchi H; Nishizaki T; Higashi H; Era S
    BMC Cancer; 2006 Jul; 6():187. PubMed ID: 16839413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The extent of proliferative and apoptotic activity in intraductal and invasive ductal breast carcinomas detected by Ki-67 labeling and terminal deoxynucleotidyl transferase-mediated digoxigenin-11-dUTP nick end labeling.
    Shen KL; Harn HJ; Ho LI; Yu CP; Chiu SC; Lee WH
    Cancer; 1998 Jun; 82(12):2373-81. PubMed ID: 9635530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Bax and Bcl-2 expression in p53-immunopositive breast cancers.
    Krajewski S; Thor AD; Edgerton SM; Moore DH; Krajewska M; Reed JC
    Clin Cancer Res; 1997 Feb; 3(2):199-208. PubMed ID: 9815673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of bax and p53 proteins in the tumorigenesis and progression of breast carcinomas.
    Redondo M; Garcia J; Rodrigo I; Villar E; González C; Morell M
    Tumour Biol; 2003; 24(1):23-31. PubMed ID: 12743423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous bilateral breast carcinomas: a category with frequent coexpression of HER-2 and ER-alpha, high Ki-67 and bcl-2, and low p53.
    Bassarova AV; Nesland JM; Sedloev T; Lilleby W; Hristova SL; Trifonov DY; Torlakovic E
    Int J Surg Pathol; 2005 Jul; 13(3):239-46. PubMed ID: 16086078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen receptor expression in relation to apoptosis and the expression of cell cycle related proteins in prostate cancer.
    Amirghofran Z; Monabati A; Gholijani N
    Pathol Oncol Res; 2004; 10(1):37-41. PubMed ID: 15029260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis, proliferation, bax, bcl-2 and p53 status prior to and after preoperative radiochemotherapy for locally advanced rectal cancer.
    Tannapfel A; Nüsslein S; Fietkau R; Katalinic A; Köckerling F; Wittekind C
    Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):585-91. PubMed ID: 9635706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferation marker MIB-1 correlates well with proliferative activity evaluated by BrdU in breast cancer: an immunohistochemical study including correlation with PCNA, p53, c-erbB-2 and estrogen receptor status.
    Moriki T; Takahashi T; Kataoka H; Hiroi M; Yamane T; Hara H
    Pathol Int; 1996 Dec; 46(12):953-61. PubMed ID: 9110347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of bcl-2 expression in ductal carcinoma in situ of the breast relates to poor histological differentiation and to expression of p53 and c-erbB-2 proteins.
    Quinn CM; Ostrowski JL; Harkins L; Rice AJ; Loney DP
    Histopathology; 1998 Dec; 33(6):531-6. PubMed ID: 9870147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo patterns of Bcl-2 family protein expression in breast carcinomas in relation to apoptosis.
    Rochaix P; Krajewski S; Reed JC; Bonnet F; Voigt JJ; Brousset P
    J Pathol; 1999 Mar; 187(4):410-5. PubMed ID: 10398099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of Bcl-2 in invasive breast cancer is associated with high rates of cell death, but also with increased proliferative activity.
    van Slooten HJ; van de Vijver MJ; van de Velde CJ; van Dierendonck JH
    Br J Cancer; 1998 Mar; 77(5):789-96. PubMed ID: 9514059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of p53 mutations, bax, and spontaneous apoptosis in maxillary sinus squamous cell carcinoma.
    Bandoh N; Hayashi T; Kishibe K; Takahara M; Imada M; Nonaka S; Harabuchi Y
    Cancer; 2002 Apr; 94(7):1968-80. PubMed ID: 11932899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of clinical parameters and biological markers in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy.
    Homma A; Furuta Y; Oridate N; Nakano Y; Kohashi G; Yagi K; Nagahashi T; Yagi K; Nagahashi T; Fukuda S; Inoue K; Inuyama Y
    Clin Cancer Res; 1999 Apr; 5(4):801-6. PubMed ID: 10213215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis in breast carcinoma.
    González-Cámpora R; Galera Ruiz MR; Vázquez Ramírez F; Ríos Martín JJ; Fernández Santos JM; Ramos Martos MM; Gómez Pascual A
    Pathol Res Pract; 2000; 196(3):167-74. PubMed ID: 10729921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.